Jefferies Says Otsuka’s Higher-Value Assets May Lift Margins

Jefferies analysts say Otsuka Holdings’ shift toward higher-value assets should lift margins and drive earnings per share above consensus in coming years. The note cites Voyxact, a drug used to reduce protein in the urine in adults with kidney disease.